EQ - Company ID 0001746466
The table below shows Equillium, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | $12.16M | $13.85M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Equillium, Inc. reported annual revenue of $41.09M for fiscal year 2024. That is up 13.9% from $36.08M in fiscal 2023. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $2.62M |
| $3.27M |
| $2.15M |
| $2.95M |
| $3.28M |
| $3.15M |
| Operating income | -$5.61M | -$4.58M | -$6.23M | -$8.87M | -$679.00K | -$100.00K |
| Income tax | - | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$5.31M | -$4.23M | -$5.74M | -$8.65M | -$7.00K | $468.00K |
| EPS (diluted) | -$0.06 | -$0.06 | -$0.16 | -$0.24 | $0.00 | $0.01 |